Call to arrange a consultation
+1 416 777 0888

Sanofi-Aventis Canada Inc. v. Hospira Healthcare Corp.

Represented Hospira Healthcare Corporation in a proceeding under the Patented Medicines (Notice of Compliance) Regulations regarding the invalidity and non-infringement of patents relating to Sanofi-Aventis' Taxotere (docetaxel) product.  The dismissal of Fournier's application is reported at 2009 FC 1077.

Meet the team